Author Archive
Big Mac please, hold the broccoli
Today we report a study merely as a reminder that just because it is in a scientific journal does not make it the Gospel. It was a very small study, out of Japan, based on self-reported dietary history questionnaires. (The accuracy of self-reported dietary histories is probably right up there Continue Reading…
Study finds startling rates of joint surgery in psoriatic arthritis patients
There’s a psoriatic arthritis study out of Denmark with some troubling statistics. The researchers looked at the Danish National Patient Registry from 1996 to 2017, and compared joint surgery rates between almost 12,000 psoriatic arthritis patients, and more than 100,000 people without psoriatic arthritis used as “controls” for comparison purposes. Continue Reading…
AbbVie, maker of Humira and Skyrizi, getting closer to third product to fight psoriatic disease
AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and a new biologic Skyrizi (risankizumab-rzaa), moved closer this week to having its new rheumatoid arthritis (RA) pill, Rinvoq (upadacitinib), approved for psoriatic arthritis. Rinvoq is a JAK inhibitor being studied for psoriatic arthritis as a once-daily pill. Continue Reading…
New study links itch in skin conditions (including psoriasis) to clinical depression
A new study has found that “the presence of itch in dermatological patients is significantly associated with clinical depression” and suicidal thoughts. The study, of more than 4,500 people across 13 European countries, compared four groups of people: those with dermatological (skin) diseases like psoriasis who reported having itch, those Continue Reading…
